One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact in the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 9,000 employees in locations spanning the globe and 2006 revenues of $3.2 billion. With many established products services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies the life sciences. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune diseases, and diagnostic testing. Genzyme's commitment to innovation continues today with a substantial development program focused on these fields, as well as heart disease and other areas of unmet medical need.